Answers are grounded in this paper and cite their sources.
Retrospective study compares mutation detection in blood samples from tumor-draining veins and peripheral blood in breast cancer, suggesting improved outcomes.
Liquid biopsy offers a minimally invasive approach for detecting tumour-derived genomic alterations in breast cancer, yet the optimal blood sampling site for maximizing diagnostic sensitivity remains unclear. This retrospective study compared the performance of standard peripheral blood collection with selective venous sampling (SVS) from tumour-draining veins to evaluate whether proximity to the tumour enhances mutation detection.
No takes yet. Share an insight, caveat, or question.
Cazzaniga et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: